Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 CD164 and other recently discovered activation markers as promising tools for allergy diagnosis: what's new?

Literature DB >> 21461759

CD164 and other recently discovered activation markers as promising tools for allergy diagnosis: what's new?

Salvatore Chirumbolo.

Abstract

Entities: Disease Gene

Mesh：

Substances：

Year: 2011 PMID： 21461759 DOI： 10.1007/s10238-011-0132-y

Source DB: PubMed Journal: Clin Exp Med ISSN： 1591-8890 Impact factor: 3.984

× No keyword cloud information.

20 in total

Review 1. CD164.

Authors: A C Zannettino
Journal: J Biol Regul Homeost Agents Date: 2001 Oct-Dec Impact factor: 1.711

2. Validation of basophil CD164 upregulation for pollen allergy diagnosis.

Authors: Anna Wolanczyk-Medrala; Wojciech Barg; Jerzy Liebhart; Bernard Panaszek; Grazyna Nadobna; Marta Litwa; Grzegorz Gogolewski; Wojciech Medrala
Journal: Arch Immunol Ther Exp (Warsz) Date: 2010-09-28 Impact factor: 4.291

Review 3. Biomarkers for allergen immunotherapy in cedar pollinosis.

Authors: Takao Fujisawa; Mizuho Nagao; Yukiko Hiraguchi; Koa Hosoki; Reiko Tokuda; Satoko Usui; Sawako Masuda; Makito Shinoda; Akihiko Hashiguchi; Masao Yamaguchi
Journal: Allergol Int Date: 2009-04-25 Impact factor: 5.836

4. Robust expression of CCR3 as a single basophil selection marker in flow cytometry.

Authors: O V Hausmann; T Gentinetta; M Fux; S Ducrest; W J Pichler; C A Dahinden
Journal: Allergy Date: 2011-01 Impact factor: 13.146

Review 5. Update on the medical treatment of allergic rhinitis.

Authors: Cemal Cingi; Gurkan Kayabasoglu; Alpen Nacar
Journal: Inflamm Allergy Drug Targets Date: 2009-06

6. The sialomucin CD164 (MGC-24v) is an adhesive glycoprotein expressed by human hematopoietic progenitors and bone marrow stromal cells that serves as a potent negative regulator of hematopoiesis.

Authors: A C Zannettino; H J Bühring; S Niutta; S M Watt; M A Benton; P J Simmons
Journal: Blood Date: 1998-10-15 Impact factor: 22.113

7. Measurement of basophil-activating capacity of grass pollen allergens, allergoids and hypoallergenic recombinant derivatives by flow cytometry using anti-CD203c.

Authors: H Kahlert; O Cromwell; H Fiebig
Journal: Clin Exp Allergy Date: 2003-09 Impact factor: 5.018

5. Identification of new cancer stem cell markers and signaling pathways in HER‑2‑positive breast cancer by transcriptome sequencing.

Authors: Lu Feng; Shangke Huang; Gaili An; Guanying Wang; Shanzhi Gu; Xinhan Zhao
Journal: Int J Oncol Date: 2019-09-12 Impact factor: 5.650

5 in total

CD164 and other recently discovered activation markers as promising tools for allergy diagnosis: what's new?

Review 1. CD164.

2. Validation of basophil CD164 upregulation for pollen allergy diagnosis.

Review 3. Biomarkers for allergen immunotherapy in cedar pollinosis.

4. Robust expression of CCR3 as a single basophil selection marker in flow cytometry.

Review 5. Update on the medical treatment of allergic rhinitis.

6. The sialomucin CD164 (MGC-24v) is an adhesive glycoprotein expressed by human hematopoietic progenitors and bone marrow stromal cells that serves as a potent negative regulator of hematopoiesis.

7. Measurement of basophil-activating capacity of grass pollen allergens, allergoids and hypoallergenic recombinant derivatives by flow cytometry using anti-CD203c.

Review 8. Diagnostic tests based on human basophils: more potentials and perspectives than pitfalls.

9. CD164, a novel sialomucin on CD34(+) and erythroid subsets, is located on human chromosome 6q21.

10. Differential response of human basophil activation markers: a multi-parameter flow cytometry approach.

1. Monitoring of CD63% in basophil activation test and suggested new parameters for allergy diagnosis.

Review 2. Immunotherapy in allergy and cellular tests: state of art.

3. CD164 regulates proliferation and apoptosis by targeting PTEN in human glioma.

4. CD164 promotes tumor progression and predicts the poor prognosis of bladder cancer.

5. Identification of new cancer stem cell markers and signaling pathways in HER‑2‑positive breast cancer by transcriptome sequencing.